A new study from the University Of Virginia School Of Medicine has discovered that oligodendrocyte progenitor cells are key contributors to the development of multiple sclerosis (MS).
These cells are...
Today is Purple Tuesday, an international call to action to customer-facing businesses to put accessibility at the forefront of their company.
Coordinated by Purple, a disability organisation, the...
Medical cannabis has been approved for use on the NHS in England for people with multiple sclerosis (MS) for the first time.
The National Institute for Health and Care Excellence (NICE) has given the...
Important work by scientists to discover how oxygen affects the body at a cellular level has been recognised with a Nobel Prize. William Kaelin of the Dana-Farber Cancer Institute and Harvard Medical...
As many as 20,000 people in the UK are going to be given medical cannabis as part of a new study aiming to create the largest body of evidence on the drug’s clinical effects.
The trial, named...
According to a new study of more than 5,000 people, late 30s might be a critical time to start drug therapy to halt the progression of multiple sclerosis (MS). Researchers told the 35th Congress of...
Researchers have identified three genes that play a role in vision loss in multiple sclerosis (MS), possibly paving the way for the development of precision medicine for the condition.
The study by...
Stem cell treatment for people living with multiple sclerosis (MS) in Scotland has been recommended on the NHS for the first time.
The Scottish Health Technologies Group, which provides evidence and...
Higher intelligence and physical exercise in childhood may help slow the development of cognitive impairment in people with multiple sclerosis (MS), a study has found.
The research, which was...
The Sapphire Medical Clinic in London this month became the first in the UK to be approved by the Care Quality Commission (CQC) to prescribe medical cannabis. The UK government legalised cannabis-...
